Cryptocurrency & Digital Assets

With its sixth deal of 2026, WhiteHawk expands its footprint in the Haynesville Shale, tying its fortunes to the booming but controversial U.S. LNG market.

The infant nutrition giant is entering Canada's booming organic market, betting on brand trust to compete in an increasingly crowded and conscious space.

With a $41M boost from a16z, Ease Health is using AI to unify a fractured behavioral health system, promising relief for overwhelmed providers.

A $1M deal offers a sliver of recovery for victims of the $71M William Jordan Ponzi scheme, putting custodian Kingdom Trust's alleged role in focus.

Amid soaring uranium prices, Refined Energy begins its maiden drill program in Saskatchewan's prolific Athabasca Basin, a high-stakes bet on nuclear's future.

SaaS growth expert Eric Shoemaker takes the helm at Keebo, aiming to scale its AI-powered platform amid soaring enterprise demand for cloud cost control.

Amid consumer complaints of bait-and-switch pricing, U-Haul introduces a price guarantee, challenging competitors and signaling a shift in the market.

Neogen divests its pioneering genomics business for $160M to slash debt, while Zoetis bolsters its dominance in the animal health diagnostics market.

Asia's largest pharma show returns, showcasing China's evolution from the world's factory to a global hub of drug innovation and supply chain strategy.

Manhattan's top landlord promotes Harrison Sitomer from intern to President, signaling a focus on stability as it navigates a complex office market.

Riding high on U.S. success, GEEK BAR returns to Europe with a reusable vape, a strategic pivot as the continent wages war on disposable products.

The New York-based bank will now originate FHA-insured loans nationwide, positioning it to capitalize on the growing demand for senior care facilities.

McFarlane Lake Mining's latest drill results reveal a massive 95.4-meter gold intersection, signaling a major expansion of its Juby gold project.

Industry legend William Sheriff moves to Verdera Energy, unlocking a major New Mexico uranium portfolio in a strategic spin-out from giant enCore Energy.

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

A key clinical milestone for its MS drug azer-cel nets Precision BioSciences $7.5M, extending its financial runway and boosting hope for patients.

HVAC giant AAON reports record 2025 sales but lower earnings due to massive investments. A $1.83B backlog signals a powerful 2026 rebound.

Space42 and Viasat's new venture, Equatys, aims to connect billions with a neutral, shared satellite network, challenging rivals like Starlink and AST.

With a 33% revenue surge, Orezone Gold is funding a transformative expansion into Canada, diversifying away from its core West African operations.

With star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.